Angiotensin II type 1 receptor blocker attenuates the activation of ERK and NADPH oxidase by mechanical strain in mesangial cells in the absence of angiotensin II

被引:24
|
作者
Yatabe, Junichi [1 ]
Sanada, Hironobu [1 ,3 ,4 ]
Yatabe, Midori Sasaki [1 ]
Hashimoto, Shigeatsu [1 ]
Yoneda, Minoru [2 ]
Felder, Robin A. [2 ]
Jose, Pedro A. [3 ,4 ]
Watanabe, Tsuyoshi [1 ]
机构
[1] Fukushima Med Univ, Dept Internal Med 3, Sch Med, Fukushima 9601295, Japan
[2] Univ Virginia Hlth Syst, Dept Pathol, Charlottesville, VA USA
[3] Georgetown Univ, Med Ctr, Dept Pediat, Washington, DC 20007 USA
[4] Georgetown Univ, Med Ctr, Dept Physiol & Biophys, Washington, DC 20007 USA
关键词
hypertension; PROTEIN-COUPLED RECEPTORS; SMOOTH-MUSCLE-CELLS; OXIDATIVE STRESS; INVERSE AGONISTS; BLOOD-PRESSURE; SALT INTAKE; EXPRESSION; STRETCH; GENERATION; RENIN;
D O I
10.1152/ajprenal.00580.2007
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Yatabe J, Sanada H, Yatabe MS, Hashimoto S, Yoneda M, Felder RA, Jose PA, Watanabe T. Angiotensin II type 1 receptor blocker attenuates the activation of ERK and NADPH oxidase by mechanical strain in mesangial cells in the absence of angiotensin II. Am J Physiol Renal Physiol 296: F1052-F1060, 2009. First published March 4, 2009; doi:10.1152/ajprenal.00580.2007.- It has been reported that mechanical strain activates extracellular signal-regulated protein kinases (ERK) without the involvement of angiotensin II (Ang II) in cardiomyocytes. We examined the effects of mechanical strain on ERK phosphorylation levels in the absence of Ang II using rat mesangial cells. The ratio of phosphorylated ERK (p-ERK) to total ERK expression was increased by cyclic mechanical strain in a time- and elongation strength-dependent manner. With olmesartan [ Ang II type 1 receptor (AT1R) antagonist] pretreatment, p-ERK plateau levels decreased in a dose-dependent manner (EC50 = 1.3 x 10(-8) M, maximal inhibition 50.6 +/- 11.0% at 10(-5) M); a similar effect was observed with RNA interference against Ang II type 1A receptor (AT(1A)R) and Tempol, a superoxide dismutase mimetic. In addition to the inhibition of p-ERK levels, olmesartan blocked the increase in cell surface and phosphorylated p47(phox) induced by mechanical strain and also lowered the mRNA expression levels of NADPH oxidase sub-units. These results demonstrate that mechanical strain stimulates AT1R to phosphorylate ERK in mesangial cells in the absence of Ang II. This mechanotransduction mechanism is involved in the oxidative stress caused by NADPH oxidase and is blocked by olmesartan. The inverse agonistic activity of this AT1R blocker may be useful for the prevention of mesangial proliferation and renal damage caused by mechanical strain/oxidative stress regardless of circulating or tissue Ang II levels.
引用
收藏
页码:F1052 / F1060
页数:9
相关论文
共 50 条
  • [1] Olmesartan attenuates the activation of ERK by cyclic mechanical strain in rat mesangial cells in the absence of angiotensin II
    Yatabe, Junichi
    Sanada, Hironobu
    Yatabe, Midori Sasaki
    Midorikawa, Sanae
    Hashimoto, Shigeatsu
    Felder, Robin A.
    Jose, Pedro A.
    Watanabe, Tsuyoshi
    JOURNAL OF HYPERTENSION, 2006, 24 : 108 - 108
  • [2] The role of the NADPH oxidase in activation of T cells by angiotensin II
    Hoch, Nyssa E.
    Guzilk, Tomasz J.
    Weyand, Cornelia M.
    Goronzy, Jorg J.
    Harrison, David G.
    HYPERTENSION, 2006, 48 (04) : E98 - E98
  • [3] The angiotensin II type 1 receptor blocker valsartan attenuates graft vasculopathy
    Tetsufumi Yamamoto
    Masataka Sata
    Daiju Fukuda
    Shinichi Takamoto
    Basic Research in Cardiology, 2005, 100 : 84 - 91
  • [4] The angiotensin II type 1 receptor blocker candesartan attenuates graft vasculopathy
    Yamamoto, T
    Fukuda, D
    Takamoto, S
    CIRCULATION, 2005, 112 (17) : U263 - U263
  • [5] The angiotensin II type 1 receptor blocker valsartan attenuates graft vasculopathy
    Yamamoto, T
    Sata, M
    Fukuda, D
    Takamoto, S
    BASIC RESEARCH IN CARDIOLOGY, 2005, 100 (01) : 84 - 91
  • [6] Angiotensin II type1 receptor blocker attenuates myocardial NADPH oxidase activity in advanced stage of hypertensive diastolic heart failure
    Nishio, Mayu
    Sakata, Yasushi
    Mano, Toshiaki
    Otani, Tomohito
    Takeda, Yasuharu
    Yoshida, Junichi
    Miwa, Takeshi
    Yamamoto, Kazuhiro
    Hon, Masatsugu
    CIRCULATION, 2006, 114 (18) : 767 - 767
  • [7] Mechanism of angiotensin II-induced superoxide production in cells reconstituted with angiotensin type 1 receptor and the components of NADPH oxidase
    Choi, Hyun
    Leto, Thomas L.
    Hunyady, Laszlo
    Catt, Kevin J.
    Bae, Yun Soo
    Rhee, Sue Goo
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (01) : 255 - 267
  • [8] Angiotensin II type 1 receptor blocker attenuates the progression of nonalcoholic steatohepatitis (NASH)
    Hirose, A.
    Ono, M.
    Saibara, T.
    Nozaki, Y.
    Takahashi, M.
    Iwasaki, S.
    Oben, J. A.
    Onishi, S.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S348 - S349
  • [9] Angiotensin II type 1 receptor blocker attenuates cell growth in vitro and in vivo
    Yu, C. C.
    Su, H. T.
    Chen, C. H.
    JOURNAL OF NEUROCHEMISTRY, 2014, 130 : 54 - 54
  • [10] The effects of antioxidant and angiotensin II type 1 receptor blocker on adipose and vascular NADPH oxidase, renin-angiotensin system, and adiponectin in metabolic syndrome
    Lee, Daeho
    Park, Doekbae
    Lee, Youngki
    Kang, Hyunwook
    Koh, Gwanpyo
    Kang, Jungsook
    DIABETES, 2006, 55 : A594 - A594